Successful Subcutaneous Desensitization to Certolizumab Pegol.

Advanced Search

M J Peñalver, S Bautista-Villanueva, R Barranco, J F Crespo, R Mielgo

Author Information

M J Peñalver: Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
S Bautista-Villanueva: Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
R Barranco: Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
J F Crespo: Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
R Mielgo: Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain.

PMID: 38275251 DOI: 10.18176/jiaci.0981

No abstract text available.

Allergy Certolizumab Desensitization Hypersensitivity TNFα inhibitor

Humans

Certolizumab Pegol

Desensitization, Immunologic

Drug Hypersensitivity

Injections, Subcutaneous

Female

Male

Middle Aged

Certolizumab Pegol

Journal Article Case Reports

OpenLB
Open Library of Bioscience